Literature DB >> 20690049

Representativity of TMA studies.

Guido Sauter1.   

Abstract

The smaller the portion of a tumor sample that is analyzed becomes, the higher is the risk of missing important histological or molecular features that might be present only in a subset of tumor cells. Many researchers have, therefore, suggested using larger tissue cores or multiple cores from the same donor tissue to enhance the representativity of TMA studies. However, numerous studies comparing the results of TMA studies with the findings from conventional large sections have shown that all well-established associations between molecular markers and tumor phenotype or patient prognosis can be reproduced with TMAs even if only one single 0.6 mm tissue spot is analyzed. Moreover, the TMA technology has proven to be superior to large section analysis in finding new clinically relevant associations. The high number of samples that are typically included in TMA studies, and the unprecedented degree of standardization during TMA experiments and analysis often give TMA studies an edge over traditional large-section studies.

Entities:  

Mesh:

Year:  2010        PMID: 20690049     DOI: 10.1007/978-1-60761-806-5_3

Source DB:  PubMed          Journal:  Methods Mol Biol        ISSN: 1064-3745


  4 in total

1.  Clinical value of CD133 and nestin in patients with glioma: a population-based study.

Authors:  Rikke H Dahlrot; Steinbjørn Hansen; Stine S Jensen; Henrik D Schrøder; Jacob Hjelmborg; Bjarne W Kristensen
Journal:  Int J Clin Exp Pathol       Date:  2014-06-15

2.  Loss of membranous VEGFR1 expression is associated with an adverse phenotype and shortened survival in breast cancer.

Authors:  Patrick Lebok; Julia Huber; Eike-Christian Burandt; Annette Lebeau; Andreas Holger Marx; Luigi Terracciano; Uwe Heilenkötter; Fritz Jänicke; Volkmar Müller; Peter Paluchowski; Stefan Geist; Christian Wilke; Ronald Simon; Guido Sauter; Alexander Quaas
Journal:  Mol Med Rep       Date:  2016-06-23       Impact factor: 2.952

3.  Detection of Putative Stem-cell Markers in Invasive Ductal Carcinoma of the Breast by Immunohistochemistry: Does It Improve Prognostic/Predictive Assessments?

Authors:  Rodrigo V Oliveira; Valéria B Souza; Philipi C Souza; Fernando A Soares; José Vassallo; Rafael M Rocha; André A Schenka
Journal:  Appl Immunohistochem Mol Morphol       Date:  2018 Nov/Dec

4.  Role of Synaptophysin, Chromogranin and CD56 in adenocarcinoma and squamous cell carcinoma of the lung lacking morphological features of neuroendocrine differentiation: a retrospective large-scale study on 1170 tissue samples.

Authors:  Katharina Kriegsmann; Christiane Zgorzelski; Thomas Muley; Petros Christopoulos; Michael Thomas; Hauke Winter; Martin Eichhorn; Florian Eichhorn; Moritz von Winterfeld; Esther Herpel; Benjamin Goeppert; Albrecht Stenzinger; Felix J F Herth; Arne Warth; Mark Kriegsmann
Journal:  BMC Cancer       Date:  2021-05-01       Impact factor: 4.430

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.